Literature DB >> 16766369

Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls.

H Demir1, F Tanriverdi, N Ozoğul, M Caliş, M Kirnap, A C Durak, F Keleştimur.   

Abstract

OBJECTIVE: To explore the hypothalamic-pituitary-adrenal (HPA) axis in polymyalgia rheumatica (PMR). SUBJECTS AND METHODS: This study was carried out on 13 female patients with PMR who were diagnosed according to the criteria of Chuang et al (Ann Intern Med 1982;97:672-80) and 10 healthy female subjects in the Department of Physical Medicine and Rehabilitation, Erciyes University Medical School. In the patient and control groups, basal cortisol, adrenocorticotrophic hormone (ACTH), 17alpha-hydroxyprogesterone (17-OHP), 11-deoxycortisol (11-S), dehydroepiandrosterone sulfate (DHEAS), androstenedione (A), prolactin (PRL), and thyroid stimulating hormone (TSH) levels were measured. Cortisol, 17-OHP, 11-S and A responses after the low-dose (1 microg) ACTH stimulation test and cortisol and DHEAS responses after the dexamethasone suppression test were detected. We also measured acute phase reactants including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).
RESULTS: Age and sex characteristics were similar in both patient and control groups. The levels of basal hormones including cortisol, ACTH, 17-OHP, 11-S, DHEAS, A, prolactin and TSH and cortisol and DHEAS levels after the low-dose dexamethasone suppression test were not significantly different between the patient and control groups. However, cortisol/CRP and ACTH/CRP ratios were significantly lower in the patient group. Cortisol and DHEAS responses after the low-dose dexamethasone suppression test were not significantly different between the patient and control groups. Cortisol response after the 1 microg ACTH stimulation test was significantly lower in the patients than in the control group, but there were no significant differences in 17-OHP, 11-S and A responses between the patients and controls. Correlation analysis showed that there was a negative correlation between peak cortisol levels after the ACTH stimulation test and disease duration, and also a positive correlation between cortisol levels after the low-dose dexamethasone suppression test and acute phase reactants including CRP and ESR.
CONCLUSION: A significant low cortisol response to ACTH stimulation was detected in the patients with PMR. In addition, a negative correlation after the 1 microg ACTH stimulation test between peak cortisol levels and disease duration was detected. These findings may indicate hypoactivation in the HPA axis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766369     DOI: 10.1080/03009740500474586

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  8 in total

Review 1.  Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-02       Impact factor: 5.346

2.  The cortisol:C-reactive protein ratio and negative affect reactivity in depressed adults.

Authors:  Edward C Suarez; John S Sundy
Journal:  Health Psychol       Date:  2017-06-26       Impact factor: 4.267

3.  Impaired hypothalamo-pituitary-adrenal axis in patients with ankylosing spondylitis.

Authors:  L Kebapcilar; O Bilgir; A Alacacioglu; Y Yildiz; A Taylan; R Gunaydin; A Yuksel; B Karaca; I Sari
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

4.  Depressogenic vulnerability and gender-specific patterns of neuro-immune dysregulation: What the ratio of cortisol to C-reactive protein can tell us about loss of normal regulatory control.

Authors:  Edward C Suarez; John S Sundy; Alaattin Erkanli
Journal:  Brain Behav Immun       Date:  2014-09-18       Impact factor: 7.217

5.  Efficacy, safety and mechanism of action of modified-release prednisone in rheumatoid arthritis.

Authors:  Lynsey Clarke; John Kirwan
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-06       Impact factor: 5.346

6.  Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment.

Authors:  Frederik Flindt Kreiner; Henrik Galbo
Journal:  Arthritis Res Ther       Date:  2012-08-15       Impact factor: 5.156

7.  Polymyalgia rheumatica following infective triggers or vaccinations: a different subset of disease?

Authors:  Paolo Falsetti; Edoardo Conticini; Caterina Acciai; Caterina Baldi; Marco Bardelli; Stefano Gentileschi; Luca Cantarini; Bruno Frediani
Journal:  Reumatologia       Date:  2020-04-30

8.  Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune Diseases.

Authors:  Natsuki Fujio; Shotaro Masuoka; Kotaro Shikano; Natsuko Kusunoki; Toshihiro Nanki; Shinichi Kawai
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.